Author:
Baleeiro R. B.,Bergami-Santos P. C.,Tomiyoshi M. Y.,Gross J. L.,Haddad F.,Pinto C. A. L.,Soares F. A.,Younes R. N.,Barbuto J. A. M.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference17 articles.
1. Engelmayer J, Larson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N (1999) Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism immune evasion. J Immunol 163:6762
2. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Riossan MC, Liu YJ, Rabourdin-Combe C (1997) Measle virus suppresses cell mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186:813
3. Hirano N, Butler MO, Xia Z, Anse´n S, von Bergwelt-Baildon MS, Neuberg D, Freeman GJ, Nadler LM (2006) Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood 107:1528
4. Hock BD, Haring LF, Steinkasserer A, Taylor KG, William N, Patton WN, McKenzie JL (2004) The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leuk Res 28:237
5. Hock BD, Kato M, McKenzie JL, Hart DN (2001) A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int Immunol 13:959
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献